219 related articles for article (PubMed ID: 24072565)
1. Inhibition of ubiquitin conjugating enzyme UBE2C reduces proliferation and sensitizes breast cancer cells to radiation, doxorubicin, tamoxifen and letrozole.
Rawat A; Gopal G; Selvaluxmy G; Rajkumar T
Cell Oncol (Dordr); 2013 Dec; 36(6):459-67. PubMed ID: 24072565
[TBL] [Abstract][Full Text] [Related]
2. Growth inhibition of estrogen receptor-positive and aromatase-positive human breast cancer cells in monolayer and spheroid cultures by letrozole, anastrozole, and tamoxifen.
Kijima I; Itoh T; Chen S
J Steroid Biochem Mol Biol; 2005 Dec; 97(4):360-8. PubMed ID: 16263272
[TBL] [Abstract][Full Text] [Related]
3. Dominant negative Ubiquitin-conjugating enzyme E2C sensitizes cervical cancer cells to radiation.
Bose MV; Gopisetty G; Selvaluxmy G; Rajkumar T
Int J Radiat Biol; 2012 Sep; 88(9):629-34. PubMed ID: 22694363
[TBL] [Abstract][Full Text] [Related]
4. Exceptionally high UBE2C expression is a unique phenomenon in basal-like type breast cancer and is regulated by BRCA1.
Qin T; Huang G; Chi L; Sui S; Song C; Li N; Sun S; Li N; Zhang M; Zhao Z; Li L; Li M
Biomed Pharmacother; 2017 Nov; 95():649-655. PubMed ID: 28881292
[TBL] [Abstract][Full Text] [Related]
5. Optimal combination of radiotherapy and endocrine drugs in breast cancer treatment.
Zeng ZJ; Li JH; Zhang YJ; Zhao ST
Cancer Radiother; 2013 Jun; 17(3):208-14. PubMed ID: 23664221
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and mechanism of action of Proellex, an antiprogestin in aromatase overexpressing and Letrozole resistant T47D breast cancer cells.
Gupta A; Mehta R; Alimirah F; Peng X; Murillo G; Wiehle R; Mehta RG
J Steroid Biochem Mol Biol; 2013 Jan; 133():30-42. PubMed ID: 22939887
[TBL] [Abstract][Full Text] [Related]
7. Letrozole sensitizes breast cancer cells to ionizing radiation.
Azria D; Larbouret C; Cunat S; Ozsahin M; Gourgou S; Martineau P; Evans DB; Romieu G; Pujol P; Pèlegrin A
Breast Cancer Res; 2005; 7(1):R156-63. PubMed ID: 15642164
[TBL] [Abstract][Full Text] [Related]
8. GP88 (PC-Cell Derived Growth Factor, progranulin) stimulates proliferation and confers letrozole resistance to aromatase overexpressing breast cancer cells.
Abrhale T; Brodie A; Sabnis G; Macedo L; Tian C; Yue B; Serrero G
BMC Cancer; 2011 Jun; 11():231. PubMed ID: 21658239
[TBL] [Abstract][Full Text] [Related]
9. The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer.
Lisztwan J; Pornon A; Chen B; Chen S; Evans DB
Breast Cancer Res; 2008; 10(4):R56. PubMed ID: 18611244
[TBL] [Abstract][Full Text] [Related]
10. Changes in vascular endothelial growth factor (VEGF) after chemoendocrine therapy in breast cancer.
Fersis N; Smyczek-Gargya B; Armeanu S; Gagulic E; Pantic L; Relakis K; Friedrich M; Wallwiener D
Eur J Gynaecol Oncol; 2004; 25(1):45-50. PubMed ID: 15053061
[TBL] [Abstract][Full Text] [Related]
11. The role of microRNA-128a in regulating TGFbeta signaling in letrozole-resistant breast cancer cells.
Masri S; Liu Z; Phung S; Wang E; Yuan YC; Chen S
Breast Cancer Res Treat; 2010 Nov; 124(1):89-99. PubMed ID: 20054641
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of UbcH10 enhances the chemosensitivity of dual drug resistant breast cancer cells to epirubicin and docetaxel.
Wang C; Pan YH; Shan M; Xu M; Bao JL; Zhao LM
Int J Mol Sci; 2015 Mar; 16(3):4698-712. PubMed ID: 25739083
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-196a post-transcriptionally upregulates the UBE2C proto-oncogene and promotes cell proliferation in breast cancer.
Han Q; Zhou C; Liu F; Xu G; Zheng R; Zhang X
Oncol Rep; 2015 Aug; 34(2):877-83. PubMed ID: 26062455
[TBL] [Abstract][Full Text] [Related]
14. Letrozole-, anastrozole-, and tamoxifen-responsive genes in MCF-7aro cells: a microarray approach.
Itoh T; Karlsberg K; Kijima I; Yuan YC; Smith D; Ye J; Chen S
Mol Cancer Res; 2005 Apr; 3(4):203-18. PubMed ID: 15831674
[TBL] [Abstract][Full Text] [Related]
15. Estrogen-regulated gene expression predicts response to endocrine therapy in patients with ovarian cancer.
Walker G; MacLeod K; Williams AR; Cameron DA; Smyth JF; Langdon SP
Gynecol Oncol; 2007 Sep; 106(3):461-8. PubMed ID: 17624412
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-conjugating enzyme UBE2C is highly expressed in breast microcalcification lesions.
Chou CP; Huang NC; Jhuang SJ; Pan HB; Peng NJ; Cheng JT; Chen CF; Chen JJ; Chang TH
PLoS One; 2014; 9(4):e93934. PubMed ID: 24699941
[TBL] [Abstract][Full Text] [Related]
17. Opposing effects of Runx2 and estradiol on breast cancer cell proliferation: in vitro identification of reciprocally regulated gene signature related to clinical letrozole responsiveness.
Chimge NO; Baniwal SK; Luo J; Coetzee S; Khalid O; Berman BP; Tripathy D; Ellis MJ; Frenkel B
Clin Cancer Res; 2012 Feb; 18(3):901-11. PubMed ID: 22147940
[TBL] [Abstract][Full Text] [Related]
18. Association of ABCB1, β tubulin I, and III with multidrug resistance of MCF7/DOC subline from breast cancer cell line MCF7.
Li W; Zhai B; Zhi H; Li Y; Jia L; Ding C; Zhang B; You W
Tumour Biol; 2014 Sep; 35(9):8883-91. PubMed ID: 24894670
[TBL] [Abstract][Full Text] [Related]
19. Dual IGF-1R/InsR inhibitor BMS-754807 synergizes with hormonal agents in treatment of estrogen-dependent breast cancer.
Hou X; Huang F; Macedo LF; Harrington SC; Reeves KA; Greer A; Finckenstein FG; Brodie A; Gottardis MM; Carboni JM; Haluska P
Cancer Res; 2011 Dec; 71(24):7597-607. PubMed ID: 22042792
[TBL] [Abstract][Full Text] [Related]
20. Effects of novel retinoic acid metabolism blocking agent (VN/14-1) on letrozole-insensitive breast cancer cells.
Belosay A; Brodie AM; Njar VC
Cancer Res; 2006 Dec; 66(23):11485-93. PubMed ID: 17145897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
